What changed
$ADI — WATCHLIST 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
Analog Devices, Inc.
🎯 FQ2 FY2026 (ends Apr) | reported May 20 | Rev $3.6B | EPS $3.09 vs $2.91 🟢 | Margin 38.1%
💡 Consensus priced in solid execution; the +6% beat was taken in stride and the stock remains expensive relative to historical and peer norms, suggesting the market already expects a best-case scenario.
🏢 Business Quality: 8/10
📊 Valuation: rich — trailing P/E 31.5x, EV/EBITDA ~25x, FCF yield ~2.4%, all at the high end of its 5-year range; DCF implies ~10% growth to justify current price.
🔮 Catalyst: FQ3 FY2026 earnings report (expected late August 2026)
⚖️ Watchlist: ADI’s premium valuation and expensive quant profile make it a risky long at current levels; wait for a pullback or evidence of accelerating growth before committing capital.
📊 Our read: WATCHLIST. Full analysis →
https://stockduty.xyz/s/ADI0701
Also in play: $NVDA $AAPL $MSFT $AVGO $MU